# The Misuse of Drugs Regulations 2001, Paragraph 5


A liquid formulation—
(a) containing a botanical extract of cannabis—
(i) with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and
(ii) where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,
(b) which is dispensed through a metered dose pump as a mucosal mouth spray, and
(c) which was approved for marketing by the Medicines and Healthcare Products Regulatory Agency on 16th June 2010

---
Source: https://www.legislation.gov.uk/uksi/2001/3998/schedule/4/paragraph/5 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-regulations-2001/schedule-4/paragraph-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.